---
title: CD21<sup>low</sup> B cells reveal a unique glycosylation pattern with hypersialylation
  and hyperfucosylation
date: '2025-02-27'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/40013136/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20250227170943&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSION: CD21^(low) B cells are hypersialylated and hyperfucosylated.
  This may implicate altered lectin-ligand interactions on the cell surface potentially
  affecting the CD21^(low) B-cell function. These glycome changes appear to be driven
  by the prominent type I immune response in complicated CVID patients. A better understanding
  of how altered glycosylation influences immune cell function could lead to new therapeutic
  ...'
disable_comments: true
---
CONCLUSION: CD21^(low) B cells are hypersialylated and hyperfucosylated. This may implicate altered lectin-ligand interactions on the cell surface potentially affecting the CD21^(low) B-cell function. These glycome changes appear to be driven by the prominent type I immune response in complicated CVID patients. A better understanding of how altered glycosylation influences immune cell function could lead to new therapeutic ...